- Home
- Publications
- Publication Search
- Publication Details
Title
Nanotechnology-enabled delivery of NQO1 bioactivatable drugs
Authors
Keywords
-
Journal
JOURNAL OF DRUG TARGETING
Volume 23, Issue 7-8, Pages 672-680
Publisher
Informa UK Limited
Online
2015-10-10
DOI
10.3109/1061186x.2015.1073296
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2015
- (2015) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Esterase-activatable β-lapachone prodrug micelles for NQO1-targeted lung cancer therapy
- (2015) Xinpeng Ma et al. JOURNAL OF CONTROLLED RELEASE
- Poly(ADP-ribose) polymerases in double-strand break repair: Focus on PARP1, PARP2 and PARP3
- (2014) Carole Beck et al. EXPERIMENTAL CELL RESEARCH
- β-Lapachone induces programmed necrosis through the RIP1-PARP-AIF-dependent pathway in human hepatocellular carcinoma SK-Hep1 cells
- (2014) E J Park et al. Cell Death & Disease
- Prodrug Strategy to Achieve Lyophilizable, High Drug Loading Micelle Formulations Through Diester Derivatives of β-Lapachone
- (2014) Xinpeng Ma et al. Advanced Healthcare Materials
- Corrigendum: Cinnamic Acid/Chloroquinoline Conjugates as Potent Agents against Chloroquine-ResistantPlasmodium falciparum
- (2013) Bianca Pérez et al. ChemMedChem
- NQO1-Mediated Synergistic Lethality in Combination With β-lapachone (β-lap) and Ionizing Radiation (IR) in Head-and-Neck Cancer (HNC)
- (2013) S. Reddy et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Catalase Abrogates -Lapachone-Induced PARP1 Hyperactivation-Directed Programmed Necrosis in NQO1-Positive Breast Cancers
- (2013) E. A. Bey et al. MOLECULAR CANCER THERAPEUTICS
- Dendrimer as nanocarrier for drug delivery
- (2013) Prashant Kesharwani et al. PROGRESS IN POLYMER SCIENCE
- Liposomal drug delivery systems: From concept to clinical applications
- (2012) Theresa M. Allen et al. ADVANCED DRUG DELIVERY REVIEWS
- An NQO1 Substrate with Potent Antitumor Activity That Selectively Kills by PARP1-Induced Programmed Necrosis
- (2012) X. Huang et al. CANCER RESEARCH
- Preclinical Development and Clinical Translation of a PSMA-Targeted Docetaxel Nanoparticle with a Differentiated Pharmacological Profile
- (2012) J. Hrkach et al. Science Translational Medicine
- Modulating Endogenous NQO1 Levels Identifies Key Regulatory Mechanisms of Action of -Lapachone for Pancreatic Cancer Therapy
- (2011) L. S. Li et al. CLINICAL CANCER RESEARCH
- Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis
- (2011) Gina M. DeNicola et al. NATURE
- β-Lapachone Significantly Increases the Effect of Ionizing Radiation to Cause Mitochondrial Apoptosis via JNK Activation in Cancer Cells
- (2011) Moon-Taek Park et al. PLoS One
- Prostate Cancer Radiosensitization through Poly(ADP-Ribose) Polymerase-1 Hyperactivation
- (2010) Y. Dong et al. CANCER RESEARCH
- -Lapachone Micellar Nanotherapeutics for Non-Small Cell Lung Cancer Therapy
- (2010) E. Blanco et al. CANCER RESEARCH
- Nanoparticles Containing Anti-inflammatory Agents as Chemotherapy Adjuvants II: Role of Plasma Esterases in Drug Release
- (2009) Xiuling Lu et al. AAPS Journal
- Cisplatin enhances the anticancer effect of β-lapachone by upregulating NQO1
- (2009) Kaoru Terai et al. ANTI-CANCER DRUGS
- Paclitaxel and beta-lapachone synergistically induce apoptosis in human retinoblastoma Y79 cells by downregulating the levels of phospho-Akt
- (2009) Antonella D'Anneo et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Multifunctional Micellar Nanomedicine for Cancer Therapy
- (2008) Elvin Blanco et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- Prodrugs: design and clinical applications
- (2008) Jarkko Rautio et al. NATURE REVIEWS DRUG DISCOVERY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started